EAM Investors LLC Purchases Shares of 14,904 Semler Scientific, Inc. (NASDAQ:SMLR)

EAM Investors LLC bought a new position in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 14,904 shares of the company's stock, valued at approximately $805,000. EAM Investors LLC owned approximately 0.16% of Semler Scientific at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Global Retirement Partners LLC increased its stake in Semler Scientific by 62.5% during the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock valued at $70,000 after purchasing an additional 500 shares during the last quarter. Sanctuary Advisors LLC raised its stake in Semler Scientific by 13.2% during the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock worth $261,000 after acquiring an additional 584 shares during the period. Jones Financial Companies Lllp bought a new position in Semler Scientific in the fourth quarter worth about $34,000. Larson Financial Group LLC acquired a new position in Semler Scientific in the fourth quarter valued at approximately $38,000. Finally, State Street Corp grew its holdings in shares of Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company's stock valued at $2,784,000 after purchasing an additional 725 shares during the last quarter. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Trading Up 11.6 %

NASDAQ:SMLR traded up $3.45 during mid-day trading on Tuesday, hitting $33.28. The stock had a trading volume of 130,988 shares, compared to its average volume of 398,956. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $81.56. The stock has a market capitalization of $319.39 million, a price-to-earnings ratio of 6.77 and a beta of 1.29. The company has a 50 day simple moving average of $38.32 and a 200-day simple moving average of $45.99.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $3.21. The business had revenue of $12.41 million during the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital boosted their price objective on Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a research report on Friday, January 24th.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.